Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

general nutrition corporation, united states - tablet - chitosan

Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nu skin (malaysia) sdn. bhd. - chitosan -

Združeni arabski emirati - angleščina - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

chitosan, vitamin c -

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

nahdi medical company, saudi arabia - hard capsule - 200 , 150 mg - chitosan , glucomannan

Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bio-energy technology sdn bhd - chitosan; red yeast rice extract (monascus purpureus)** -

Nigerija - angleščina - NAFDAC (National Agency for Food and Drugs Administration and Control)

vitamin c 45mg, chitosan 1000mg, gymnema silvestre 200mg, garcinia cambogia extract 50mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

phytos co., ltd. - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), panthenol (unii: wv9cm0o67z) (panthenol - unii:wv9cm0o67z) - niacinamide 0.025 in 25 ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nanocuretech - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) -

Singapur - angleščina - HSA (Health Sciences Authority)

arqon pte. ltd. - general hospital - maxiocel® is intended for the management of moderate to heavily exuding chronic and acute wounds. maxiocel® may be used to control minor bleeding in superficial wounds and management of post- debridement wounds. maxiocel®can be used for the management of the following wounds under the supervision of medical professionals.➢ pressure sores➢ venous ulcers➢ diabetic ulcers➢ leg ulcers➢ cavity wounds➢ donor sites and graft sites➢ surgical wounds (e.g. post- operative, wounds left to heal by secondary intent)➢ skin abrasions and lacerations➢ superficial and partial thickness burns➢ infected wounds or wounds in which there is an increased risk of infections. maxiocel® can be used for the management of the following wounds ➢ minor cuts➢ minor scalds and 1st degree burns➢ abrasions➢ lacerations

Indija - angleščina - Central Drugs Standard Control Organization

biological e. - chitosan,psyllium - cap - 500,150;mg - 10